InMotion Musculoskeletal Institute Announces Selling of Laboratory Naming Rights to Baptist Memorial Health Care
The InMotion Musculoskeletal Institute announces that Baptist Memorial Health Care has agreed to purchase naming rights for one of InMotion's interim laboratories, which will open in January 2007.
The terms are that Baptist will pay $300,000 over two years. In return, InMotion will name its biologics laboratory the "Baptist Musculoskeletal Biologics Laboratory." Also, InMotion will create a plaque to be displayed outside the laboratory to identify the space, as well as give formal recognition to Baptist during InMotion's open-house ceremony to be held in February 2007.
As part of the agreement, InMotion will carry over the naming rights of the newly named laboratory from its interim space to its permanent facilities, which will be part of the UT-Baptist Research Park Phase I Building, to be completed in estimated 2009.
In the immediate future, InMotion plans to sell naming rights to its second existing laboratory, which has a biomechanics focus. Also, InMotion plans to sell naming rights to three other planned laboratories it will build and open at its current location, 20 South Dudley. In each case, the naming rights will carry over to InMotion's permanent laboratories.
Along with opening its first laboratory space in January 2007, InMotion is recruiting clinician scientists through a joint appointment with the University of Tennessee Health Science Center Department of Orthopaedic Surgery – Campbell Clinic. Under a similar partnership, InMotion is recruiting a Director of Biomechanics with the University of Memphis Department of Biomedical Engineering.
InMotion has received funding from multiple local foundations to support its activities, including The Hyde Family Foundations, The Campbell Foundation, The Assisi Foundation of Memphis, Inc., The Plough Foundation, and The Thomas W. Briggs Foundation. InMotion has received charitable corporate support from Medtronic and has signed multiple corporate contract agreements to perform pre-clinical and clinical research for local and national orthopaedic implant and pharmaceutical companies.
December 2006
Tags:None
|